The establishment of a multi-stakeholder platform (MSP) enabling regular dialogue between regulators and clinical trials stakeholders is one of the priority actions of the Accelerating Clinical Trials in the European Union (ACT EU) multi-annual workplan 2022-2026.
In this context, a first multi-stakeholder workshop was held on 22 and 23 June 2023, to understand different stakeholder perspectives on how to improve the EU environment for clinical trials and agree on a model for the platform.
The summary report of the workshop is now available:
- Útgáfudagsetning
- 21 September 2023
- Höfundur
- European Medicines Agency
